Cedars Sinai Medical Center
United States of America
Richard Tuli, MD, PhD, is an attending radiation oncologist in the Department of Radiation Oncology and a member of the Samuel Oschin Cancer Institute. Tuli's clinical and research interests are in gastrointestinal (GI) oncology. He is active in developing the multidisciplinary management of GI cancer patients. His research interests include investigating novel radiotherapy techniques to improve outcomes and minimize toxicity, and identifying radiosensitizing agents for treating cancer. Current research is directed toward PARP inhibitors, immunotherapies and other novel drugs in combination with radiation. Tuli has published over 140 research articles, abstracts and book chapters. His research has appeared in several peer-reviewed journals. His awards include the ASCO Cancer Foundation Merit Award, AACR Scholar-in-Training Award and Hyman Menduke Research Prize. Tuli is a member of professional organizations including the American Society for Radiation Oncology, the American Society of Clinical Oncology and th American Association for Cancer Research. In addition to presenting his research at numerous national and international conferences, Tuli serves as a manuscript reviewer for peer-reviewed journals. After earning his medical degree from Jefferson Medical College, he completed his residency in radiation oncology at Johns Hopkins Hospital, where he served as chief resident. Tuli completed a pre-doctoral fellowship at the National Institutes of Health.
Anal Cancers Colorectal Cancer (Colon, Rectal) Esophageal Cancers Liver Cancers Lung Cancers Pancreatic Cancers Stereotactic Radiosurgery Stomach (Gastric) Cancers